Myra Simon provides strategic insight to health plans, providers, drug manufacturers, and advocacy organizations to help them understand existing federal healthcare policy, identify how policy proposals impact their businesses, and develop advocacy plans.

She applies over 20 years of experience working with health plans to help clients navigate the Affordable Care Act and emerging health reform proposals. She has expertise in commercial insurance product lines, improving access to comprehensive coverage, benefit design, health plan operations, and strategic planning.

Prior to joining Avalere, Myra worked at the trade association America’s Health Insurance Plans helping health plans develop and advocate for policies to increase coverage affordability and improve the consumer experience. Before that, she worked in a variety of roles at Cambia Health Solutions.

Myra has a BA and MA from Lewis and Clark College in Portland, Oregon.

Authored Content


Consumers ages 50–64 could see higher exchange premiums starting in 2023 without extension of ARPA subsidies.

As Congress considers the bipartisan infrastructure package and budget reconciliation agenda, the coming months are likely to include debate on what could be the most significant federal healthcare legislation in over a decade. Additionally, the Biden administration is expected to release several important healthcare rules this fall, including the details necessary to implement the new law banning surprise billing and regulations to protect and strengthen Medicaid and the Affordable Care Act (ACA).

Avalere analysis shows that the COVID-19 pandemic had disproportionate impacts by race and ethnicity on Medicare enrollees.

While access to insurance has increased for millions, mid-year plan switching can have unforeseen consequences for patients.

Tune into another episode of Avalere Health Essential Voice in our Start Your Day with Avalere series. In this segment, our policy experts discuss the topic of healthcare price transparency in terms of policy, compliance, and the potential impact of making previously confidential pricing information public.

Avalere analysis finds that Congress's healthcare reforms under the COVID-19 relief bill could expand exchange coverage subsidies for up to 18.3 million individuals.

Implementation of copay accumulator and maximizer programs continues to increase; recent policy provisions finalized through federal rulemaking and state-level legislation have created new uncertainty for the future of these programs and the stakeholders they affect.

Join Avalere’s panel of market access and policy experts to learn about the shifting insurance coverage landscape and how these trends impact manufacturers, payers, policymakers, and providers.

New analysis from Avalere finds that 102 million individuals, not enrolled in major public programs like Medicaid or Medicare, have a pre-existing medical condition and could therefore face higher premiums or significant out-of-pocket costs if the ACA’s pre-existing condition protections were repealed.